# Erasca, Inc. (ERAS): Dividend & Fundamentals

> Markdown mirror of https://www.dividenddata.com/stocks/eras for AI agents. Same live data as the HTML page, regenerated on the same refresh cycle. Not investment advice.

- Sector: Healthcare · Industry: Biotechnology
- Exchange: NASDAQ · Trading currency: USD

Erasca, Inc. is a biopharmaceutical company in the clinical development stage, primarily focused on identifying, advancing, and commercializing therapeutic solutions for malignancies propelled by the RAS/MAPK pathway. The firm's pipeline features several key experimental drugs: ERAS-007, an orally administered ERK1/2 inhibitor designed to address non-small cell lung cancer, colorectal cancer, and acute myeloid leukemia; and ERAS-601, an oral SHP2 inhibitor targeting patients with advanced or metastatic solid tumors. Additionally, Erasca is progressing ERAS-801, an EGFR inhibitor capable of...

## Quote & Key Metrics

As of 2026-10-27:

| Metric | Value |
|---|---|
| Price | $15.00 USD |
| Market Cap | $5.24B |
| P/E (TTM) | — |
| EPS (TTM) | −$0.95 |
| 52-Week Range | $2.11 – $24.28 |
| Dividend Yield (TTM) | — |

## Dividend

ERAS has no dividend payment history in our records.

## Frequently Asked Questions

### What does Erasca, Inc. do?

Erasca, Inc. (ERAS) operates in the Biotechnology industry within the Healthcare sector. Full company description, peers, and segment breakdown are on the page above.

### What is ERAS's market cap?

Erasca, Inc. (ERAS) has a market capitalization of approximately $5.24 billion, as of October 27, 2026, based on the most recent share price and shares outstanding.

### Does ERAS pay a dividend?

No, Erasca, Inc. (ERAS) does not currently pay a regular dividend. Many growth-stage companies reinvest earnings into the business instead of returning capital to shareholders. The Dividend tab tracks any future declarations.

### Is ERAS profitable?

Erasca, Inc. (ERAS) currently reports negative earnings on a trailing-twelve-month basis. The Earnings and Financials tabs show the full EPS history, revenue trend, and analyst forecasts for future profitability.

### Has ERAS ever paid a dividend?

No. Dividend Data's records show no dividend payments from Erasca, Inc. (ERAS). A first dividend would appear on the Dividend tab once it is declared.

## More on Dividend Data

- Overview (HTML): https://www.dividenddata.com/stocks/eras
- Dividend history & safety: https://www.dividenddata.com/stocks/eras/dividend
- Earnings & EPS: https://www.dividenddata.com/stocks/eras/earnings
- Financial statements: https://www.dividenddata.com/stocks/eras/financials/income
- Valuation multiples: https://www.dividenddata.com/stocks/eras/valuation
- Peer comparison: https://www.dividenddata.com/stocks/eras/peers

Data sourced from primary filings and market data providers; see https://www.dividenddata.com/methodology.